More recently, clinical studies have identified patients with inborn activating mutations in NRF2 (NFE2L2), and these patients manifest with a multisystem disorder that involves a failure to thrive, immunodeficiency, and neurological symptoms (18). Here, NFE2L2 is linked to immune system disorder.